Digital pathology and computational pathology have become an integral part of the drug discovery and development process and are playing an increasingly important role...
Cell coding company bit.bio has announced an expansion to its product portfolio - ioGlutamatergic Neurons TDP-43M337V disease model and early access to its ioMicroglia...
Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and Mission Bay Capital BioLabs ("MBC BioLabs"), a life-science incubator, today...
Artisan Bio, a world-leader in CRISPR genome engineering technology, announced the launch of its CRISPR-based 1-stop shop developed from the company's proprietary STAR-CRISPR platform....
Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value...
